Lil­ly’s Pre­vail taps Jen­nifer Doud­na's spin­out Scribe Ther­a­peu­tics for neu­ro ge­net­ic med­i­cines

Scribe Ther­a­peu­tics found an­oth­er part­ner, this time with Pre­vail Ther­a­peu­tics, a sub­sidiary of Eli Lil­ly, in a $75 mil­lion up­front deal for neu­ro­mus­cu­lar and neu­ro­log­i­cal …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER